A long-time partnership between the Tucson Fire Department and researchers at the University of Arizona Health Sciences provided evidence that occupational exposure as a firefighter causes cancer.
Many studies, including several by the University of Arizona Health Sciences in collaboration with the Tucson Fire Department, contributed evidence that led the International Agency for Research on Cancer to determine occupational exposure as a firefighter causes cancer.Continue reading
One-of-a-kind online study looks for ways to reduce cognitive decline as we age
Technology developed by TGen researchers could help fine-tune future vaccinesContinue reading
Jacque Sokolov, MD, CEO of SSB Solutions, was named as one of the Directorship 100 at an award ceremony in New York City on June 22, 2022. The Directorship 100 is a recognition of the most influential people in the boardroom and corporate governance community and is bestowed by the National Association of Corporate Directors (NACD)
The 2022 D100 comprises 50 directors and 50 governance professionals and institutions who exemplify the knowledge, leadership, and excellence NACD promotes. Awardees play a significant role in shaping the greater boardroom agenda.
A University of Arizona Health Sciences study of COVID-19 vaccine effectiveness and immunity among frontline workers, families and children has received a $22 million award from the U.S. Centers for Disease Control and Prevention (CDC) to continue the research for another year.Continue reading
James Foley, entrepreneur and a long-time friend, advocate, and active member of AZBio, passed on Monday, July 4th, after his 11-month fight with a rare abdominal cancer. He was 58-years young.Continue reading
TUCSON, Ariz.- The University of Arizona Center for Innovation (UACI) is thrilled to announce its win as the Soft Landings Designee of the Year which was announced at the 36th International Conference on Business Incubation (ICBI36) hosted by the International Business Innovation Association (InBIA). Continue reading
St. Louis, MO and Holbrook, AZ, July 11, 2022 — Arizona Algae Products, LLC, a leading algae producer and innovative biotechnology company and Nooter/Eriksen, Inc., a global leader in sustainable energy, today announced that the companies have entered into a strategic partnership for the development and commercialization of extracted and refined algae products, with an initial focus on algal EPA omega-3 oils. The partnership leverages the companies’ complementary skill sets in advancing the methods and production capabilities for a variety of algae products.Continue reading
On June 24th, 2022 Rowpar was acquired by Arcadia Consumer Health Care. Arcadia provides simple, efficacious, high quality solutions to help you achieve the harmony of feeling good and looking good. The acquisition includes the ClōSYS Oral Care brand. Rowpar Pharmaceuticals Inc., remains a subsidiary of Arcadia Consumer Healthcare Inc.Continue reading
TUCSON, AZ / ACCESSWIRE / July 5, 2022 / Aqualung Therapeutics, an early stage immunotherapeutics biotech company developing an anti-inflammatory therapeutic platform for serious unchecked inflammatory disorders, announced today that their first two patients have been enrolled in the phase 1A healthy human volunteer Study. The data from this study will be used to understand and validate dosing and safety of the humanized monoclonal antibody therapeutic ALT-100 for future clinical trials that address diseases driven by unchecked inflammation.Continue reading